Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Immunotherapy and molecular role of T-cell in PD-1 antibody treated resectable lung cancer patients.

Literature DB >> 30233838

Immunotherapy and molecular role of T-cell in PD-1 antibody treated resectable lung cancer patients.

Samaresh Sau¹, Arun K Iyer^1,2.

Abstract

Entities: Disease Species

Year: 2018 PMID： 30233838 PMCID： PMC6129935 DOI： 10.21037/jtd.2018.07.66

Source DB: PubMed Journal: J Thorac Dis ISSN： 2072-1439 Impact factor: 2.895

× No keyword cloud information.

21 in total

1. IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells.

Authors: Zhaojun Sun; Julien Fourcade; Ornella Pagliano; Joe-Marc Chauvin; Cindy Sander; John M Kirkwood; Hassane M Zarour
Journal: Cancer Res Date: 2015-02-26 Impact factor: 12.701

2. STCRDab: the structural T-cell receptor database.

Authors: Jinwoo Leem; Saulo H P de Oliveira; Konrad Krawczyk; Charlotte M Deane
Journal: Nucleic Acids Res Date: 2018-01-04 Impact factor: 16.971

Review 3. Advances in antibody-drug conjugates: A new era of targeted cancer therapy.

Authors: Samaresh Sau; Hashem O Alsaab; Sushil Kumar Kashaw; Katyayani Tatiparti; Arun K Iyer
Journal: Drug Discov Today Date: 2017-06-13 Impact factor: 7.851

Review 4. Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

Authors: Samaresh Sau; Hashem O Alsaab; Ketki Bhise; Rami Alzhrani; Ghazal Nabil; Arun K Iyer
Journal: J Control Release Date: 2018-01-31 Impact factor: 9.776

5. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

Authors: Manish J Butte; Mary E Keir; Theresa B Phamduy; Arlene H Sharpe; Gordon J Freeman
Journal: Immunity Date: 2007-07-12 Impact factor: 31.745

6. Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle.

Authors: Samaresh Sau; Pritha Agarwalla; Sudip Mukherjee; Indira Bag; Bojja Sreedhar; Manika Pal-Bhadra; Chitta Ranjan Patra; Rajkumar Banerjee
Journal: Nanoscale Date: 2014-06-21 Impact factor: 7.790

Immunotherapy and molecular role of T-cell in PD-1 antibody treated resectable lung cancer patients.

1. IL10 and PD-1 Cooperate to Limit the Activity of Tumor-Specific CD8+ T Cells.

2. STCRDab: the structural T-cell receptor database.

Review 3. Advances in antibody-drug conjugates: A new era of targeted cancer therapy.

Review 4. Multifunctional nanoparticles for cancer immunotherapy: A groundbreaking approach for reprogramming malfunctioned tumor environment.

5. Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.

6. Cancer cell-selective promoter recognition accompanies antitumor effect by glucocorticoid receptor-targeted gold nanoparticle.

7. Phenotype-genotype correlation in multiple primary lung cancer patients in China.

8. A molecular signature of lung cancer: potential biomarkers for adenocarcinoma and squamous cell carcinoma.

9. A CARP-1 functional mimetic loaded vitamin E-TPGS micellar nano-formulation for inhibition of renal cell carcinoma.

10. Palindromic nucleotide analysis in human T cell receptor rearrangements.

Review 1. Tumor-related stress regulates functional plasticity of MDSCs.